Evaluation of the Oral Antihyperglycemic Drug Metformin in Normal and Diabetic Cats

Journal of Veterinary Internal Medicine

Volumn 18, Issue 1, 2004, Pages 18-24

  Nelson, Richard ^a   Spann, Dennis ^a,b   Elliott, Denise ^a   Brondos, Angela ^a   Vulliet, Richard ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Loomis Basin Veterinary Clinic   (United States)

Author keywords

Feline; Hyperglycemia; Lactic acidosis; Noninsulin dependent diabetes mellitus

Indexed keywords

ANTIDIABETIC AGENT; INSULIN; LACTIC ACID; METFORMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOACCUMULATION; BLOOD CELL COUNT; CAT DISEASE; CONTROLLED STUDY; DOSE CALCULATION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERANCE; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; INSULIN TREATMENT; LACTATE BLOOD LEVEL; LETHARGY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; URINALYSIS; VOMITING; WEIGHT REDUCTION;

ADMINISTRATION, ORAL; ANIMALS; CAT DISEASES; CATS; DIABETES MELLITUS, TYPE 2; DRUG ADMINISTRATION SCHEDULE; HYPOGLYCEMIC AGENTS; LACTIC ACID; MALE; METFORMIN;

ANIMALIA; FELIDAE; FELIS CATUS;

EID: 0842330499     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1892/0891-6640(2004)18<18:EOTOAD>2.0.CO;2     Document Type: Article

References (23)

1. Gerich JE. Oral hypoglycemic agents. N Engl J Med 1989;321: 1231-1245.
2. Bailey CJ, Turner RC. Metformin. N Engl J Med 1996;334:574-579.
3. Fanghanel G, Sanchez-Reyes L, Trujillo C, et al. Metformin's effects of glucose and lipid metabolism in patients with secondary failure to sulfonylureas. Diabetes Care 1996;19:1185-1189.
4. Abbasi F, Kamath V, Rizvi A, et al. Results of a placebo-controlled study of the metabolic effects of the addition of metformin to sulfonylurea-treated patients. Diabetes Care 1997;20:1863-1869.
5. UK Prospective Diabetes Study Group. UKPDS 28: A randomized trial of efficacy of early addition of metformin in sulfonylurea-treated type 2 diabetes. Diabetes Care 1998;21:87-92.
6. Sambol NC, Chiang J, O'Connor M, et al. Pharmacokinetics and pharmacodynamics of metformin in healthy subjects and patients with non-insulin-dependent diabetes mellitus. J Clin Pharmacol 1996;36: 1012-1021.
7. DeFronzo RA. Pharmacologic therapy for type 2 diabetes mellitus. Ann Intern Med 1999;131:281-303.
8. DeFronzo RA, Goodman AM. Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group. N Engl J Med 1995;333:541-549.
9. Brown JB, Pedula K, Barzilay J, et al. Lactic acidosis rates in type 2 diabetes. Diabetes Care 1998;21:1659-1663.
10. Stang M, Wysowski DK, Butler-Jones D. Incidence of lactic acidosis in metformin users. Diabetes Care 1999;22:925-927.
11. Michels GM, Boudinot FD, Ferguson DC, et al. Metformin: Pharmacokinetics of the antihyperglycemic agent metformin in cats. Am J Vet Res 1999;60:738-742.
12. Scheen AJ. Clinical pharmacokinetics of metformin. Clin Pharmacokinet 1996;30:359-371.
13. Nelson RW, Himsel CA, Feldman EC, et al. Glucose tolerance and insulin response in normal weight and obese cats. Am J Vet Res 1990;51:1357-1362.
14. Reusch CE, Liehs MR, Hoyer M, et al. Fructosamine. A new parameter for diagnosis and metabolic control in diabetic dogs and cats. J Vet Intern Med 1993;7:177-182.
15. Elliott DA, Nelson RW, Reusch CE, et al. Comparison of serum fructosamine and blood glycosylated hemoglobin concentrations for assessment of glycemic control in cats with diabetes mellitus. J Am Vet Med Assoc 1999;214:1794-1798.
16. Elliott DA, Nelson RW, Feldman EC, et al. Glycosylated hemoglobin concentration for assessment of glycemic control in diabetic cats. J Vet Intern Med 1997;11:161-165.
17. Benzi L, Marchetti P, Cecchetti P, Navalesi R. Determination of metformin and phenformin in human plasma and urine by reversed-phase high-performance liquid chromatography. J Chromatogr 1986; 375:1884-1889.
18. Noel M. Kinetic study of normal and sustained release dosage forms of metformin in normal subjects. Res Clin Forums 1979;1:39-49.
19. Riddle MC. Oral pharmacologic management of type 2 diabetes. Am Fam Physician 1999;60:2613-2620.
20. Nelson RW, Feldman EC, Ford SL, et al. Effect of an orally administered sulfonylurea, glipizide, for treatment of diabetes mellitus in cats. J Am Vet Med Assoc 1993;203:821-827.
21. Feldman EC, Nelson RW, Feldman MS. Intensive 50-week evaluation of glipizide administration in 50 cats with previously untreated diabetes mellitus. J Am Vet Med Assoc 1997;210:772-777.
22. Miller AB, Nelson RW, Kirk CA, et al. Effect of glipizide on serum insulin and glucose concentrations in healthy cats. Res Vet Sci 1992;52:177-181.
23. Nelson RW, Griffey SM, Feldman EC, et al. Transient clinical diabetes mellitus in cats: 10 cases (1989-1991). J Vet Intern Med 1999;13:28-35.